Progressive Care Delivers
Strong November Sales
MIAMI, FL-- (December 15, 2016 - InvestorsHub NewsWire) -
Progressive Care Inc. (OTC PINK:
RXMD), through its subsidiary Pharmco LLC, a South Florida
health services organization and provider of prescription
pharmaceuticals specializing in health practice risk management,
compounded medications, the sale of anti-retroviral medications and
related medication therapy management, and the supply of
prescription medications to long term care facilities, announces
strong November sales.
PharmCo, LLC bested expectations in November, delivering $1.7
million on 18,500 prescriptions filled in the pharmacy. This is a
31% and 23% increase over November 2015, respectively. PharmCo
continues to increase revenue by demonstrating the healthcare
benefits of the accountable care organization model. PharmCo has
developed market awareness in the South Florida healthcare
community for its independently developed pharmacy methodology,
which has caused numerous unsolicited requests for service from
clinics and doctors office networks.
"Pharmacy services have always played a major role in the health
and wellness of patients," stated S. Parikh Mars, CEO. "As the
industry moves toward shared risk across the healthcare system, the
pharmacy becomes even more vital to lowering the probability of
negative health outcomes. Our systems and team of professional
technicians and pharmacists have allowed us to offer an
unparalleled package of services to our patients as well as the
providers and insurance payers who care for them."
About Progressive Care
Progressive Care, Inc. (OTC PINK:
RXMD), through its subsidiary PharmCo, LLC, is a South Florida
health services organization and provider of prescription
pharmaceuticals specializing in health practice risk management,
compounded medications, the sale of anti-retroviral medications and
related medication therapy management, and the supply of
prescription medications to long term care facilities.
Cautionary Statement Regarding Forward Looking Statements
Statements contained herein that are not based upon current or
historical fact are forward-looking in nature and constitute
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange
Act of 1934. Such forward-looking statements reflect the Companys
expectations about its future operating results, performance and
opportunities that involve substantial risks and uncertainties.
These statements include but are not limited to statements
regarding the intended terms of the offering, closing of the
offering and use of any proceeds from the offering. When used
herein, the words anticipate, believe, estimate, upcoming, plan,
target, intend and expect and similar expressions, as they relate
to Progressive Care Inc., its subsidiaries, or its management, are
intended to identify such forward-looking statements. These
forward-looking statements are based on information currently
available to the Company and are subject to a number of risks,
uncertainties, and other factors that could cause the Company's
actual results, performance, prospects, and opportunities to differ
materially from those expressed in, or implied by, these
forward-looking statements.
Contact
Armen Karapetyan
Senior Advisor Business Development
armen@progressivecareus.com